Description of Research Expertise:
Pulmonary Hypertension
Heart Failure with Reduced Ejection Fraction
Heart Failure with Preserved Ejection Fraction
Hemodynamics
Cardiopulmonary Exercise Testing
Biomarkers
Echocardiography
Right Ventricular Failure
Selected Publications:
Kawut SM, Pinder D, Al-Naamani N, McCormick A, Palevsky HI, Fritz J, Smith KA, Mazurek JA, Doyle MF, MacLean MR, DeMichele A, Mankoff DA.: Fulvestrant for the Treatment of Pulmonary Arterial Hypertension.
Annals American Thoracic Society 16 (11): 1456-1459,2019.
Ruth BK, Bilchick KC, Mysore MM, Mwansa H, Harding WC, Kwon Y, Kennedy JLW, Mazurek JA, Mihalek AD, Smith LA, Mejia-Lopez E, Parker AM, Welch TS, Mazimba S.: Increased Pulmonary-Systemic Pulse Pressure Ratio Is Associated With Increased Mortality in Group 1 Pulmonary Hypertension. Heart Lung Circ 28 (7): 1059-66,2019.
Menachem JN, Reza N, Mazurek JA, Burstein D, Birati EY, Fox A, Kim YY, Molina M, Partington SL, Tanna M, Tobin L, Wald J, Goldberg LR.: Cardiopulmonary Exercise Testing-A Valuable Tool, Not Gatekeeper When Referring Patients With ACHD for Transplant Evaluation.
World J Pediatr Congenit Heart Surg 10 (3): 286-291,2019.
Kim YY, Awh K, Acker M, Atluri P, Bermudez C, Crespo M, Diamond JM, Drajpuch D, Forde-Mclean R, Fuller S, Goldberg L, Mazurek J, Mascio C, Menachem JN, Rame E, Ruckdeschel E, Tobin L, Wald J.: Pulmonary arterial hypertension in adults with systemic right ventricles referred for cardiac transplantation.
Clin Transplant 33 (4): e13496,2019.
Estephan LE, Genuardi MV, Kosanovich C, Risbano MG, Zhang Y, Petro N, Watson A, Al Aaraj Y, Sembrat J, Rojas M, Goncharov D, Simon M, Goncharova E, Vaidya A, Smith A, Mazurek J, Han Y, Chan SY.: Distinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertension.
Pulm Circ 9 (2): 2019.
Bhattacharya PT, Troutman GS, Mao F, Fox A, Tanna MS, Zamani P, Grandin W, Menachem JN, Birati EY, Chirinos JA, Mazimba S, Smith A, Kawut SM, Forfia P, Vaidya A, Mazurek JA.: Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: A noninvasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension. Pulm Circ 9 (2): 2019.
Birati EY, Hanff TC, Maldonado D, Grandin EW, Kennel PJ, Mazurek JA, Vorovich E, Seigerman M, Howard JLL, Acker MA, Naka Y, Wald J, Goldberg LR, Jessup M, Atluri P, Margulies KB, Schulze PC, Rame JE: Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score. J Am Heart Assoc 7 (6): e006408,2018.
Han Yuchi, Forfia Paul R, Vaidya Anjali, Mazurek Jeremy A, Park Myung H, Ramani Gautam, Chan Stephen Y, Waxman Aaron B: Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension. Open heart 5 (1): e000736,2018.
Gopal DJ, Hanff TC, Mazurek, JA, Grandin WE, Howard J, Forde-McLean R, Wald J, King K, Acker MA, Goldberg LR, Jessup M, Atluri P, Margulies KB, Rame EJ, Birati EY.: Prognostic Implications of Changes in Albumin Following Left Ventricular Assist Device Implantation in Patients with Severe Heart Failure. Am J Cardiol 120 (11): 2003-2007,2017.
Mazure JA, Horne BD, Saeed W, Sardar MR, Zolty R: Galectin-3 Levels are elevated and Predictive of Mortality in Pulmonary Hypertension Heart Lung Circ 26 (11): 1208-15,2017.
View all publications